Volume 58, Issue 1 pp. 273-283
Autoimmune, Cholestatic and Biliary Disease
Free Access

Impact of primary biliary cirrhosis on perceived quality of life: The UK-PBC national study§

George F. Mells

George F. Mells

Department of Hepatology Cambridge University Hospitals NHS Foundation Trust Cambridge UK

Academic Department of Medical Genetics Cambridge University Cambridge UK

These authors contributed equally to this study.

Search for more papers by this author
Greta Pells

Greta Pells

Institute of Cellular Medicine Newcastle University Newcastle-upon-Tyne UK

These authors contributed equally to this study.

Search for more papers by this author
Julia L. Newton

Julia L. Newton

NIHR Biomedical Research Center in Ageing & Chronic Disease Newcastle-upon-Tyne UK

Search for more papers by this author
Andrew J. Bathgate

Andrew J. Bathgate

Scottish Liver Transplant Unit Royal Infirmary of Edinburgh Edinburgh UK

Search for more papers by this author
Andrew K. Burroughs

Andrew K. Burroughs

Hepatology Dept. Royal Free Campus, University College London UK

Search for more papers by this author
Michael A. Heneghan

Michael A. Heneghan

Institute of Liver Studies King's College Hospital NHS Foundation Trust London UK

Search for more papers by this author
James M. Neuberger

James M. Neuberger

Liver Unit Queen Elizabeth Hospital Birmingham UK

Search for more papers by this author
Darren B. Day

Darren B. Day

Academic Department of Medical Genetics Cambridge University Cambridge UK

Search for more papers by this author
Samantha J. Ducker

Samantha J. Ducker

Institute of Cellular Medicine Newcastle University Newcastle-upon-Tyne UK

Search for more papers by this author
Richard N. Sandford

Richard N. Sandford

Academic Department of Medical Genetics Cambridge University Cambridge UK

Search for more papers by this author
Graeme J. Alexander

Graeme J. Alexander

Department of Hepatology Cambridge University Hospitals NHS Foundation Trust Cambridge UK

Academic Department of Medical Genetics Cambridge University Cambridge UK

Search for more papers by this author
David E.J. Jones

Corresponding Author

David E.J. Jones

Institute of Cellular Medicine Newcastle University Newcastle-upon-Tyne UK

NIHR Biomedical Research Center in Ageing & Chronic Disease Newcastle-upon-Tyne UK

fax: +44 191 222 0723.

Institute of Cellular Medicine, Level 4 William Leech Building, Newcastle University, Framlington Place, Newcastle upon Tyne NE2 4HH, UK===Search for more papers by this author
UK-PBC Consortium
First published: 07 March 2013
Citations: 168

Potential conflict of interest: nothing to report.

For a list of members of the UK-PBC Consortium, please see the Appendix

§

Supported in part by the National Institute for Health Research (NIHR) Newcastle Biomedical Research Center based at Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University; Isaac Newton Trust, University of Cambridge PBC Foundation. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or Dept. of Health. Further funding was provided by Wellcome Trust & MRC Addenbrooke's Charitable Trust. The PBC Genetics Study is a portfolio study of the NIHR CRN.

Abstract

Primary biliary cirrhosis (PBC) has a complex clinical phenotype, with debate about the extent and specificity of frequently described systemic symptoms such as fatigue. The aim of this study was to use a national patient cohort of 2,353 patients recruited from all clinical centers in the UK to explore the impact of disease on perceived life quality. Clinical data regarding diagnosis, therapy, and biochemical status were collected and have been reported previously. Detailed symptom phenotyping using recognized and validated symptom assessment tools including the PBC-40 was also undertaken and is reported here. Perception of poor quality of life and impaired health status was common in PBC patients (35% and 46%, respectively) and more common than in an age-matched and sex-matched community control group (6% and 15%, P < 0.0001 for both). Fatigue and symptoms of social dysfunction were associated with impaired perceived quality of life using multivariate analysis. Fatigue was the symptom with the greatest impact. Depression was a significant factor, but appeared to be a manifestation of complex symptom burden rather than a primary event. Fatigue had its greatest impact on perceived quality of life when accompanied by symptoms of social dysfunction, suggesting that maintenance of social networks is critical for minimizing the impact of fatigue. Conclusion: The symptom burden in PBC, which is unrelated to disease severity or ursodeoxycholic acid response, is significant and complex and results in significant quality of life deficit. The complexity of symptom burden, and its lack of relation to disease severity and treatment response, suggest that specific approaches to symptom management are warranted that address both symptom biology and social impact. (Hepatology 2013;58:-)

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.